Baigalmaa Jantsansengee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Baigalmaa Jantsansengee has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Battur Lkhagvaa
The National Center for Public Health, Ulaanbaatar, Mongolia
2 shared publications - Amarjargal Dagvadorj
Department of Health Policy, National Center for Child Health and Development, Tokyo, Japan
1 shared publication Amartuvshin Tumenjargal
Department of Obstetrics and Gynaecology, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
1 shared publicationAnkhjargal Zanaa
Department of Public Health, Graduate School of Medicine, Gunma University, Maebashi, Japan
1 shared publication- Anuujin Gantumur
Department of Microbiology and Infection Prevention Control, School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
1 shared publication - Badmaarag Munkhjin
Department of Chemical and Biological Engineering National University of Mongolia Ulaanbaatar Mongolia
1 shared publication
Latest Publications
- 8 October 2024
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 36 (8) , 784-787
A Snapshot of the Tuberculosis situation in Mongolia: in Association with COVID-19
- 8 October 2024
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 36 (8) , 784-787
A Snapshot of the Tuberculosis situation in Mongolia: in Association with COVID-19
- Open Access
- 13 December 2023
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 11 (12) , e1095
Molecular epidemiology of SARS‐CoV‐2 in Mongolia, first experience with nanopore sequencing in lower‐ and middle‐income countries setting
Background: Coronavirus disease (COVID‐19) has had a significant impact globally, and extensive genomic research has been conducted on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) lineage patterns and its variants. Mongolia's effective response resulted in low prevalence until vaccinations became available. However, due to the lack of systematically collected data and absence of whole genome sequencing capabilities, we conducted a two‐stepped, nationally representative molecular epidemiologic study of SARS‐CoV‐2 in Mongolia for 2020 and 2021.Methods: We used retrospective analysis of stored biological samples from November 2020 to October 2021 and a variant‐specific real‐time reverse transcription polymerase chain reaction (RT‐PCR) test to detect SARS‐CoV‐2 variants, followed by whole genome sequencing by Nanopore technology. Samples were retrieved from different sites and stored at −70°C deep freezer, and tests were performed on samples with cycle threshold <30.Results: Out of 4879 nucleic acid tests, 799 whole genome sequencing had been carried out. Among the stored samples of earlier local transmission, we found the 20B (B.1.1.46) variant predominated in the earlier local transmission period. A slower introduction and circulation of alpha and delta variants were observed compared to global dynamics in 2020 and 2021. Beta or Gamma variants were not detected between November 2020 and September 2021 in Mongolia.Conclusions: SARS‐CoV‐2 variants of concerns including alpha and delta were delayed in circulation potentially due to public health stringencies in Mongolia. We are sharing our initial experience with whole genome sequencing of SARS‐CoV‐2 from Mongolia, where sequencing data is sparse.
- 13 December 2023
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 11 (12) , e1095
Open AccessMolecular epidemiology of SARS‐CoV‐2 in Mongolia, first experience with nanopore sequencing in lower‐ and middle‐income countries setting
Background: Coronavirus disease (COVID‐19) has had a significant impact globally, and extensive genomic research has been conducted on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) lineage patterns and its variants. Mongolia's effective response resulted in low prevalence until vaccinations became available. However, due to the lack of systematically collected data and absence of whole genome sequencing capabilities, we conducted a two‐stepped, nationally representative molecular epidemiologic study of SARS‐CoV‐2 in Mongolia for 2020 and 2021.Methods: We used retrospective analysis of stored biological samples from November 2020 to October 2021 and a variant‐specific real‐time reverse transcription polymerase chain reaction (RT‐PCR) test to detect SARS‐CoV‐2 variants, followed by whole genome sequencing by Nanopore technology. Samples were retrieved from different sites and stored at −70°C deep freezer, and tests were performed on samples with cycle threshold <30.Results: Out of 4879 nucleic acid tests, 799 whole genome sequencing had been carried out. Among the stored samples of earlier local transmission, we found the 20B (B.1.1.46) variant predominated in the earlier local transmission period. A slower introduction and circulation of alpha and delta variants were observed compared to global dynamics in 2020 and 2021. Beta or Gamma variants were not detected between November 2020 and September 2021 in Mongolia.Conclusions: SARS‐CoV‐2 variants of concerns including alpha and delta were delayed in circulation potentially due to public health stringencies in Mongolia. We are sharing our initial experience with whole genome sequencing of SARS‐CoV‐2 from Mongolia, where sequencing data is sparse.
- Open Access
- 25 March 2022
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 21, 100436
Health emergency preparedness and response to the COVID-19 pandemic: Lessons learnt from Mongolia
- 25 March 2022
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 21, 100436
Open AccessHealth emergency preparedness and response to the COVID-19 pandemic: Lessons learnt from Mongolia